Summers L K, Clark M L, Humphreys S M, Bugler J, Frayn K N
Nuffield Department of Clinical Medicine, Radcliffe Infirmary, Oxford, UK.
Horm Metab Res. 1999 Jul;31(7):424-8. doi: 10.1055/s-2007-978767.
As a result of the Diabetes Control and Complications Trial, there is increased emphasis on the importance of blood glucose concentration self-monitoring for people with diabetes. The current methods for this are not ideal, and there are many other possible techniques currently under investigation. One of these techniques is microdialysis, which can be used to analyse subcutaneous interstitial glucose concentrations. A system with high recovery has recently been used to monitor glucose concentrations with sampling over one- or two-hour periods. We have investigated whether this system can be used to monitor rapid changes in blood glucose concentration in healthy volunteers with collection intervals of only ten minutes. The results show that microdialysis can be used to monitor rapidly changing blood glucose concentration, but in some subjects, dialysate glucose lagged behind the whole blood and plasma glucose concentrations to a degree that would be clinically significant. It would therefore be necessary to assess the system, comparing dialysate with plasma glucose concentrations in each individual, prior to use in a clinical setting.
由于糖尿病控制与并发症试验,人们越来越重视糖尿病患者自我监测血糖浓度的重要性。目前用于此目的的方法并不理想,目前还有许多其他可能的技术正在研究中。其中一种技术是微透析,可用于分析皮下组织间液中的葡萄糖浓度。最近,一种具有高回收率的系统已被用于在一到两小时的时间段内进行采样来监测葡萄糖浓度。我们研究了该系统是否可用于在仅十分钟的采集间隔下监测健康志愿者血糖浓度的快速变化。结果表明,微透析可用于监测快速变化的血糖浓度,但在一些受试者中,透析液葡萄糖浓度落后于全血和血浆葡萄糖浓度的程度在临床上具有显著意义。因此,在临床环境中使用之前,有必要对该系统进行评估,将每个个体的透析液葡萄糖浓度与血浆葡萄糖浓度进行比较。